| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | RG-108 | CTRPv2 | pan-cancer | AAC | 0.07 | 0.05 |
| mRNA | necrostatin-1 | CTRPv2 | pan-cancer | AAC | -0.071 | 0.06 |
| mRNA | selumetinib:BRD-A02303741 (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.067 | 0.06 |
| mRNA | pac-1 | CTRPv2 | pan-cancer | AAC | 0.067 | 0.06 |
| mRNA | Epothilone B | GDSC1000 | pan-cancer | AAC | 0.069 | 0.06 |
| mRNA | THZ-2-102-1 | GDSC1000 | pan-cancer | AAC | 0.059 | 0.06 |
| mRNA | PLX4720 | CTRPv2 | pan-cancer | AAC | -0.065 | 0.06 |
| mRNA | GSK-1904529A | GDSC1000 | pan-cancer | AAC | -0.066 | 0.07 |
| mRNA | KIN001-102 | GDSC1000 | pan-cancer | AAC | 0.058 | 0.07 |
| mRNA | THZ-2-49 | GDSC1000 | pan-cancer | AAC | 0.057 | 0.07 |